JPRN-UMIN000032737已完成未知
Efficacy and safety of etanercept for non-infectious lung complications after allogeneic stem cell transplantation - Etanercept for non-infectious lung complications after allogeneic stem cell transplantation
Department of hematology, Hamamatsu university school of medicine0 个研究点目标入组 20 人开始时间: 2018年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who do not consent to this study 2. Patients considered ineligible for this study by physicians
研究者
相似试验
招募中
不适用
Clinical Efficacy of Etanercept in Patients with Rheumatoid Arthritis and its Associated DiseasesRheumatoid arthritisJPRN-UMIN000013368Osaka Medical College30
尚未招募
4 期
Prospective study on the effects of etanercept treatment in patients with rheumatoid arthritis who are naive for TNF-alpha blocking therapy or are non-responders to prior treatment with other anti-TNF-alpha medicatio1000381610023213rheumatoid arthritisNL-OMON32681Academisch Medisch Centrum200
进行中(未招募)
不适用
Prospective study on the effects of etanercept treatment in patients with rheumatoid arthritis who are naïve for TNF-alpha blocking therapy and patients who do not respond (anymore) to prior treatment with other anti-TNF-alpha medication - Not applicablerheumatoid arthritisMedDRA version: 12.0Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2009-015653-20-NL
进行中(未招募)
不适用
Studies on the combined treatment using etanercept and ultraviolet B for patients with moderate to severe psoriasis vulgarisPsoriasis vulgaris (Plaque-Typ)MedDRA version: 9.1Level: LLTClassification code 10050576Term: Psoriasis vulgarisEUCTR2008-000106-37-DEKlinik für Dermatologie und Allergologie der RUB, St. Josef Hospital
已完成
4 期
Effectiveness of Etanercept Biosimilar Initiating for Etanercept -Naive Patients, using Ultrasound, Clinical and Biomarker Assessments in Outcomes of Real World Therapy(ENPORT-NGSK Study):Study protocol for an interventional, multicenter, open-label, single-arm clinical trialRheumatoid arthritisJPRN-jRCTs071200054Kawakami Atsushi40
